Harvard Bioscience (HBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2012 | 12-2011 | 09-2011 | 06-2011 | 03-2011 | |
| Sales | 28,322 | 29,028 | 26,381 | 27,143 | 26,312 |
| Cost of Goods | 14,922 | 15,868 | 14,503 | 14,358 | 13,943 |
| Gross Profit | 13,400 | 13,160 | 11,878 | 12,785 | 12,369 |
| Operating Expenses | 13,093 | 10,312 | 12,161 | 10,624 | 11,362 |
| Operating Income | 1,229 | 3,716 | 220 | 2,519 | 1,950 |
| Interest Expense | 147 | 149 | 216 | 192 | 195 |
| Other Income | -238 | -256 | -122 | -327 | -80 |
| Pre-tax Income | 844 | 3,311 | -118 | 2,000 | 1,675 |
| Income Tax | 315 | 1,096 | -146 | 630 | -1 |
| Net Income Continuous | 529 | 2,215 | 28 | 1,370 | 1,676 |
| Net Income | $529 | $738 | $28 | $1,370 | $1,676 |
| EPS Basic Total Ops | 0.20 | 0.30 | 0.00 | 0.50 | 0.60 |
| EPS Basic Continuous Ops | 0.20 | 0.82 | 0.01 | 0.48 | 0.59 |
| EPS Diluted Total Ops | 0.20 | 0.20 | 0.00 | 0.50 | 0.60 |
| EPS Diluted Continuous Ops | 0.20 | 0.77 | 0.01 | 0.45 | 0.57 |
| EBITDA(a) | $2,317 | $4,856 | $1,361 | $3,642 | $2,964 |